Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Mast cells act as pro-angiogenic and pro-tumorigenic players in pituitary gonadotroph tumors.

Neuro-oncology·2025

Same author

Clinical Pharmacology of Asciminib: A Review.

Clinical pharmacokinetics·2024

Same author

First-in-human safety, tolerability, and pharmacokinetic results of DFV890, an oral low-molecular-weight NLRP3 inhibitor.

Clinical and translational science·2024

Same author

Assessment of matrix effect in quantitative LC-MS bioanalysis.

Bioanalysis·2024

Same author

Differentiation is accompanied by a progressive loss in transcriptional memory.

BMC biology·2024

Same author

Metabolite Bioanalysis in Drug Development: Recommendations from the IQ Consortium Metabolite Bioanalysis Working Group.

Clinical pharmacology and therapeutics·2023

Same journal

A simple, sensitive microsample LC-MS assay for quercetin and isorhamnetin in mouse and human plasma: application to EMIQ treatment in myotonic dystrophy type 1.

Bioanalysis·2026

Same journal

ADA assays for high-dose biologics: redefining drug tolerance through clinical insights.

Bioanalysis·2026

Same journal

Comparison of SERS spectral data sets of blood serum samples of hypopharyngeal cancer using silver and gold nanoparticles as substrates.

Bioanalysis·2026

Same journal

The Gyrolab platform for immunogenicity assessment and biotherapeutic and biomarker analysis: technical advances and bioanalytical applications.

Bioanalysis·2026

Same journal

Simultaneous quantification of D-penicillamine, D-penicillamine disulfide, and L-cysteine-D-penicillamine disulfide in human plasma: optimization of sample preparation and mass spectrometry procedures to support bioequivalence studies.

Bioanalysis·2026

Same journal

Development and preliminary clinical application of a time-resolved fluoroimmunoassay for anti-rituximab antibodies in membranous nephropathy.

Bioanalysis·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 12, 2025

Large Scale Non-targeted Metabolomic Profiling of Serum by Ultra Performance Liquid Chromatography-Mass Spectrometry UPLC-MS

Large Scale Non-targeted Metabolomic Profiling of Serum by Ultra Performance Liquid Chromatography-Mass Spectrometry UPLC-MS

Published on: March 14, 2013

Inclusion of dilution quality control samples in quantitative LC-MS bioanalysis.

Wenkui Li¹, Yunlin Fu¹, Franck Picard²

¹Pharmacokinetic Sciences, Novartis Biomedical Research, East Hanover, NJ 07936, USA.

|September 26, 2024

Summary

This summary is machine-generated.

Sample dilution in LC-MS bioanalysis ensures accurate results by managing analyte concentrations and reducing matrix effects. Following good practices and demonstrating dilution integrity are crucial for reliable bioanalytical data.

Keywords:

LC-MS bioanalysis dilution dilution QCs dilution factor dilution integrity pre-dilution

More Related Videos

A Strategy for Sensitive, Large Scale Quantitative Metabolomics

A Strategy for Sensitive, Large Scale Quantitative Metabolomics

Published on: May 27, 2014

Cellular Lipid Extraction for Targeted Stable Isotope Dilution Liquid Chromatography-Mass Spectrometry Analysis

Cellular Lipid Extraction for Targeted Stable Isotope Dilution Liquid Chromatography-Mass Spectrometry Analysis

Published on: November 17, 2011

Related Experiment Videos

Last Updated: Jun 12, 2025

Large Scale Non-targeted Metabolomic Profiling of Serum by Ultra Performance Liquid Chromatography-Mass Spectrometry UPLC-MS

Large Scale Non-targeted Metabolomic Profiling of Serum by Ultra Performance Liquid Chromatography-Mass Spectrometry UPLC-MS

Published on: March 14, 2013

A Strategy for Sensitive, Large Scale Quantitative Metabolomics

A Strategy for Sensitive, Large Scale Quantitative Metabolomics

Published on: May 27, 2014

Cellular Lipid Extraction for Targeted Stable Isotope Dilution Liquid Chromatography-Mass Spectrometry Analysis

Cellular Lipid Extraction for Targeted Stable Isotope Dilution Liquid Chromatography-Mass Spectrometry Analysis

Published on: November 17, 2011

Area of Science:

Analytical Chemistry
Pharmacokinetics
Biotechnology

Background:

Liquid Chromatography-Mass Spectrometry (LC-MS) is a key technique in bioanalysis.
Sample dilution is often necessary to quantify analytes within the dynamic range of the assay.
Matrix effects can interfere with accurate analyte measurement in biological samples.

Discussion:

Dilution is critical for managing analyte concentrations and mitigating matrix effects in LC-MS bioanalysis.
Adherence to regulatory guidelines for sample preparation is essential.
Demonstrating dilution integrity is a mandatory step in validating bioanalytical methods.

Key Insights:

Proper sample dilution ensures analyte concentrations fall within the validated dynamic range.
Dilution can effectively alleviate matrix effects, improving accuracy and precision.
Dilution integrity must be proven for all diluted samples within an analytical run.

Outlook:

Standardized good dilution practices will enhance the reliability of bioanalytical studies.
Future research may focus on automated dilution strategies for high-throughput bioanalysis.
Continued emphasis on regulatory compliance ensures the integrity of drug development data.